We are live on ! Find out more
IMMU

Immunomedics Inc
IMMU

Delisted

IMMU was delisted on the 22nd of October, 2020.

Back to rankings

79 hedge funds and large institutions have $162M invested in Immunomedics Inc in 2013 Q2 according to their latest regulatory filings, with 79 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

8% more call options, than puts

Call options by funds: $9.63M | Put options by funds: $8.91M

Holders
79
Holders Change
+79
Holders Change %
–
% of All Funds
2.58%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
79
Increased
–
Reduced
–
Closed
–
Calls
$9.63M
Puts
$8.91M
Net Calls
+$723K
Net Calls Change
+$723K

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
Fidelity Investments
1
Fidelity Investments
Massachusetts
$62.2M +$37.6M +11,439,971 New
BFA
2
BlackRock Fund Advisors
California
$14.1M +$8.52M +2,595,088 New
Vanguard Group
3
Vanguard Group
Pennsylvania
$13.7M +$8.28M +2,521,447 New
BIT
4
BlackRock Institutional Trust
California
$13M +$7.87M +2,396,511 New
State Street
5
State Street
Massachusetts
$6.63M +$4M +1,218,461 New
Northern Trust
6
Northern Trust
Illinois
$5.77M +$3.49M +1,061,267 New
PA
7
Perceptive Advisors
New York
$4.02M +$2.43M +739,144 New
WCM Investment Management
8
WCM Investment Management
California
$2.68M +$1.62M +494,216 New
PAM
9
Panagora Asset Management
Massachusetts
$2.65M +$1.6M +486,860 New
Susquehanna International Group
10
Susquehanna International Group
Pennsylvania
$2.64M +$1.6M +485,624 New
B
11
Bailard
California
$2.53M +$1.53M +465,000 New
Dimensional Fund Advisors
12
Dimensional Fund Advisors
Texas
$2.21M +$1.33M +406,085 New
Bank of New York Mellon
13
Bank of New York Mellon
New York
$2.15M +$1.3M +394,614 New
TCIM
14
TIAA CREF Investment Management
New York
$1.75M +$1.06M +322,009 New
Geode Capital Management
15
Geode Capital Management
Massachusetts
$1.62M +$981K +298,585 New
GCP
16
GSA Capital Partners
United Kingdom
$1.47M +$888K +270,490 New
BCM
17
Bridgeway Capital Management
Texas
$1.44M +$867K +264,100 New
OAM
18
Oxford Asset Management
United Kingdom
$1.37M +$828K +251,955 New
Charles Schwab
19
Charles Schwab
California
$1.28M +$763K +232,300 New
BIM
20
BlackRock Investment Management
Delaware
$1.08M +$653K +198,760 New
EI
21
EAM Investors
California
$1.03M +$621K +188,919 New
Deutsche Bank
22
Deutsche Bank
Germany
$1.02M +$615K +187,368 New
Citadel Advisors
23
Citadel Advisors
Florida
$956K +$577K +175,659 New
BP
24
Banyan Partners
Florida
$952K +$575K +175,000 New
RFC
25
Russell Frank Company
Washington
$806K +$487K +148,209 New
1
2 3 4

IMMU Hedge Fund Activity: Q2 2013 in Review

79 of the 3,064 institutional investors tracked by Wall St. Rank reported a position in Immunomedics Inc (IMMU) for Q2 2013, worth a combined $162M.

Buyers outnumbered sellers: 79 funds opened new IMMU positions and 0 closed out — a net gain of 79 holders — while 0 added to existing stakes and 0 trimmed.

  • 79 institutional investors held Immunomedics Inc (IMMU) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $162M of Immunomedics Inc stock for Q2 2013.
  • 79 funds opened new Immunomedics Inc positions in Q2 2013 and 0 closed out, a net change of +79 holders.

Based on aggregated 13F filings for Q2 2013.